L 316/4 Official Journal of the European Union 26.11.2008 DIRECTIVES COMMISSION DIRECTIVE 2008/ 107/EC of 25 November 2008 amending Council Directive 91/414/EEC to include abamectin, epoxiconazole, fenpropimorph, fenpyroximate and tralkoxydim as active substances (Text with EEA relevance) THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market (1), and in particular Article 6(1) thereof, Whereas: ( ( ( ) ) ’) Commission Regulations (EC) No 451/2000 (?) and (EC) No 1490/2002 (}) lay down the detailed rules for the implementation of the third stage of the programme of work referred to in Article 8(2) of Directive 91/414/EEC and establish a list of active substances to be assessed, with a view to their possible inclusion in Annex I to Directive 91/414/EEC. That list includes abamectin, epox- iconazole, fenpropimorph, fenpyroximate and tralk- oxydim. For those active substances the effects on human health and the environment have been assessed in accordance with the provisions laid down in Regulations (EC) No 451/2000 and (EC) No 1490/2002 for a range of uses proposed by the notifiers. Moreover, those Regulations designate the rapporteur Member States which have to submit the relevant assessment reports and recommen- dations to the European Food Safety Authority (EFSA) in accordance with Article 10(1) of Regulation (EC) No 1490/2002. For abamectin the rapporteur Member State was the Netherlands and all relevant information was submitted on 27 October 2005. For epoxiconazole, fenpropimorph and fenpyroximate the rapporteur Member State was Germany and all relevant information 230, 19.8.1991, p. 1. 55, 29.2.2000, p. 25. o L o L 0] L 224, 21.8.2002, p. 23. ) was submitted on 28 April 2005, 17 March 2005 and 25 October 2005 respectively. For tralkoxydim the rapporteur Member State was the United Kingdom and all relevant information was submitted on 6 September 2005. The assessment reports have been peer reviewed by the Member States and the EFSA and presented to the Commission on 29 May 2008 for abamectin, on 26 March 2008 for epoxiconazole and tralkoxydim, on 14 April 2008 for fenpropimorph, on 5 May 2008 for fenpyroximate in the format of the EFSA Scientific Reports (4. These reports have been reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and finalised on 11 July 2008 in the format of the Commission review reports for abamectin, epoxiconazole, fenpropimorph, fenpyroximate and tralkoxydim. It has appeared from the various examinations made that plant protection products containing abamectin, epoxico- nazole, fenpropimorph, fenpyroximate and tralkoxydim may be expected to satisfy, in general, the requirements laid down in Article 5(1)(@@) and (b) of Directive 91/414[EEC, in particular with regard to the uses which were examined and detailed in the Commission review reports. It is therefore appropriate to include these active substances in Annex [, in order to ensure that in all Member States the authorisations of plant protection products containing these active substances can be granted in accordance with the provisions of that Directive. EFSA Scientific Report (2008) 148. Conclusion regarding the peer review of the pesticide risk assessment of the active substance abamectin (finalised 29 May 2008). EFSA Scientific Report (2008) 138. Conclusion regarding the peer review of the pesticide risk assessment of the active substance epox- iconazole (finalised 26 March 2008). EFSA Scientific Report (2008) 144. Conclusion regarding the peer review of the pesticide risk assessment of the active substance fenpropimorph (finalised 14 April 2008). EFSA Scientific Report (2008) 143, Conclusion regarding the peer review of the pesticide risk assessment of the active substance fenpyroximate (finalised 5 May 2008). EFSA Scientific Report (2008), Conclusion regarding the peer review of the pesticide risk assessment of the active substance tralkoxydim (finalised 26 March 2008).